Leverone Jason A. — SEC insider filings

SEC reporting owner CIK 1692747. 12 insider filings on record with FilingPulse; latest filed 2026-09-23.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2021-01-20 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
OnKure Therapeutics, Inc. (OKUR)Chief Financial Officer11—8 legs · 4,936 sh · $15,07313
Viridian Therapeutics, Inc.\DE (VRDN)Chief Financial Officer1——1

Insider filings — Leverone Jason A.

FiledFormIssuerReported transactionsSource
2026-09-234OnKure Therapeutics, Inc. (OKUR)Sale (S): 302 @ $2.97EDGAR
2026-08-114OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 50,000 (derivative) @ $0 · Disposition to issuer (D): 5,781 (derivative) · Grant/award (A): 5,781 (derivative) · Disposition to issuer (D): 5,322 (derivative) · Grant/award (A): 5,322 (derivative) · Disposition to issuer (D): 130,611 (derivative) · +1 moreEDGAR
2026-06-244OnKure Therapeutics, Inc. (OKUR)Sale (S): 303 @ $4.40EDGAR
2026-04-034OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 110,000 (derivative) @ $0EDGAR
2026-03-244OnKure Therapeutics, Inc. (OKUR)Sale (S): 301 @ $4.16EDGAR
2025-12-234OnKure Therapeutics, Inc. (OKUR)Sale (S): 302 @ $2.97EDGAR
2025-09-244OnKure Therapeutics, Inc. (OKUR)Sale (S): 303 @ $2.62EDGAR
2025-06-254OnKure Therapeutics, Inc. (OKUR)Sale (S): 303 @ $2.38EDGAR
2025-04-084OnKure Therapeutics, Inc. (OKUR)Sale (S): 1,278 @ $3.33 · Sale (S): 1,844 @ $2.67EDGAR
2025-01-294OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-10-084OnKure Therapeutics, Inc. (OKUR)Grant/award (A): 16,331 · Grant/award (A): 5,781 (derivative) · Grant/award (A): 5,322 (derivative) · Grant/award (A): 130,611 (derivative) @ $0EDGAR
2021-01-204Viridian Therapeutics, Inc.\DE (VRDN)Grant/award (A): 311,785 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1692747 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs